Sign up to see all 5.
Sign up to see all 5.
A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
GG
GordonMD Global Investments LP
|
10.0M | 12.00% | +5.9M (+143.2%) | Q4 '25 | 14.6% | |
|
Shares held by quarter
Peak holding10.0M (Q2'26)
Change over 8 quarters+10.0M
Share of the company12.000%
|
||||||
|
P
Pfizer Inc
|
7.0M | 8.42% | Unchanged | 2024 | 11.4% | |
|
Shares held by quarter
Peak holding7.0M (Q4'24)
Change over 8 quarters+7.0M
Share of the company8.420%
|
||||||
28 more super investors behind a free account
See every manager holding Pyxis Oncology, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$4.28M | 1.4M | 1.70% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$1.68M | 558.8K | 0.67% | 0.00% | June 30, 2026 |
18 more funds behind a free account
See every fund holding Pyxis Oncology, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LS
Lara Sullivan, M.D.
5%+ holder
13D · 11.2%
|
7.5M | 9.03% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
CP
Connealy Pamela Ann
Insider
|
3.4M | 4.10% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company4.100%
|
||||||
3 more holders behind a free account
See every insider and 5%+ holder of Pyxis Oncology, Inc..
Sign up freeLoading...